Association of plasma XIIa with risk of stroke
Institution:Radcliffe Infirmary, University of Oxford
Principal Investigator:
Professor Peter Rothwell
Region: South East
Grant value: £66,491 over 24 months
Start date: February 2007
Status: ongoing
Damage to the endothelium (the blood vessel lining) is important in the development of atherosclerosis (hardening of the arteries) and complications, such as strokes. The research team have developed a test that might detect this process early on.
Factor XII is a molecule which becomes activated and is bound by another receptor molecule in blood vessels, triggering the process that causes blood clots to form - and hence strokes. Pilot studies carried out by the research team show that measurement of the activated molecule and the receptor in the blood of patients who have had a TIA ("mini-stroke") might well identify those patients at high risk of major stroke.
The aim of this project is to study a large sample of patients to reliably determine whether we can predict further events over and above existing clinical risk scores. If so, the test could be a useful predictor in routine clinical practice, and would identify the activated Factor XII and the receptor molecule as targets for novel treatments to prevent stroke.
Classification:
Prevention, Epidemiology